T Cells

Multiple Myeloma Patient Blood Cell Donors Drive New Therapy Progress

MMRF Funds Critical Research Relying on Patients Multiple Myeloma Research Foundation + NexImmune Partnership MMRF’s mission to advance new multiple myeloma therapy into clinical trials for MM patients includes a new formal partnership with NexImmune. A world leader in cancer research, the MMRF’s investment will advance NexImmune’s promising immuno oncology drug candidate NEXI-002 and support…